Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dr Reddy's Laboratories

13.92
-0.0200-0.14%
Post-market: 14.020.1000+0.72%16:06 EDT
Volume:1.24M
Turnover:17.25M
Market Cap:11.60B
PE:18.51
High:13.99
Open:13.97
Low:13.84
Close:13.94
Loading ...

Dr. Reddy's Laboratories Slides Tuesday, Underperforms Competitors

Dow Jones
·
29 Apr

Asian Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
28 Apr

Asian Equities Traded in the US as American Depositary Receipts Lower in Friday Trading; End Week Up 5%

MT Newswires Live
·
25 Apr

Dr. Reddy's Laboratories Slides Friday, Outperforms Competitors

Dow Jones
·
25 Apr

Asian Equities Traded in the US as American Depositary Receipts Surge in Wednesday Trading

MT Newswires Live
·
23 Apr

Dr. Reddy's Laboratories Rallies Wednesday, Underperforms Competitors

Dow Jones
·
23 Apr

Bausch (BHC) Moves 13.3% Higher: Will This Strength Last?

Zacks
·
21 Apr

Dr. Reddy's Laboratories Climbs Monday, Underperforms Competitors

Dow Jones
·
21 Apr

Investing in ReadyTech Holdings (ASX:RDY) five years ago would have delivered you a 56% gain

Simply Wall St.
·
21 Apr

Dr. Reddy’s says report of 25% workforce cost reduction ‘incorrect’

TIPRANKS
·
15 Apr

Dr Reddy's Says Reported Job Cuts 'Factually Incorrect'

MT Newswires Live
·
15 Apr

Dr. Reddy’s Laboratories (RDY): Among the Best Indian Stocks to Buy According to Billionaires

Insider Monkey
·
14 Apr

Asian Equities Traded in the US as American Depositary Receipts Tumble in Thursday Trading

MT Newswires Live
·
10 Apr

Asian Equities Traded in the US as American Depositary Receipts Sharply Lower in Monday Trading

MT Newswires Live
·
07 Apr

Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading

MT Newswires Live
·
03 Apr

Dr. Reddy's Signs Commercialization, License Deals for Bio-Thera Biosimilars in Southeast Asia

MT Newswires Live
·
28 Mar

Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia

PR Newswire
·
27 Mar

Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading

MT Newswires Live
·
27 Mar

Dr. Reddy's Laboratories Currently Up Eight Consecutive Days, on Track for Longest Winning Streak Since March 2019 -- Data Talk

Dow Jones
·
25 Mar

Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
20 Mar